Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -125,609 | -77,109 | -32,611 | -146,969 | -108,175 |
| Depreciation Amortization | 92 | 49 | 734 | 297 | 163 |
| Accounts payable and accrued liabilities | 333 | 823 | 2,132 | 2,085 | 3,525 |
| Other Working Capital | 10,433 | 3,280 | 518 | 15,022 | 12,184 |
| Other Operating Activity | 14,057 | 8,373 | 1,453 | 78,521 | 66,282 |
| Operating Cash Flow | $-100,694 | $-64,584 | $-27,774 | $-51,044 | $-26,021 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -189,639 | -208,299 | -196,795 | -123,500 | -115,141 |
| PPE Investments | -2,438 | -1,727 | -347 | -21,211 | -3,168 |
| Other Investing Activity | -2,000 | -2,000 | -1,000 | 0 | -17,721 |
| Investing Cash Flow | $-194,077 | $-212,026 | $-198,142 | $-144,711 | $-136,030 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 28,222 | 28,222 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -40 | -40 |
| Common Stock Issued | 291,838 | 291,469 | 291,344 | N/A | 0 |
| Other Financing Activity | 0 | 0 | 0 | 300,899 | 303,043 |
| Financing Cash Flow | $320,060 | $319,691 | $291,344 | $300,859 | $303,003 |
| Beginning Cash Position | 105,419 | 105,419 | 105,419 | 315 | 315 |
| End Cash Position | 130,708 | 148,500 | 170,847 | 105,419 | 141,267 |
| Net Cash Flow | $25,289 | $43,081 | $65,428 | $105,104 | $140,952 |
| Free Cash Flow | |||||
| Operating Cash Flow | -100,694 | -64,584 | -27,774 | -51,044 | -26,021 |
| Capital Expenditure | -2,438 | -1,727 | -347 | -3,490 | -3,168 |
| Free Cash Flow | -103,132 | -66,311 | -28,121 | -54,534 | -29,189 |